2025-03-11 03:51:07
Latest Post
NTPC Group to Invest Rs 96,000 Crore in Chhattisgarh
Arvind Fashions aims to expand its CLUB A stores across India
Somany Ceramics Elevates Luxury with the launch of Duragres 2025 Collection
Cosmo Films Bags SIES SOP Star Awards 2025 for Innovative Packaging Materials
Zaggle Prepaid Ocean Services Ltd receives 'Financial Institution of the Year' Award
Stock Report
Glenmark Life Sciences Ltd Q4 FY2022-23 PAT soars to Rs. 146.35 crores
Posted On : 2023-04-28 00:22:17( TIMEZONE : IST )
Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 624.156 crores during the period ended March 31, 2023 as compared to Rs. 547.339 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 146.357 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 104.993 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 11.94 for the period ended March 31, 2023 as compared to Rs. 8.57 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹624.156 crs | ₹547.339 crs |  14.03% |
| Net Profit | ₹146.357 crs | ₹104.993 crs | 39.40% |
| EPS | ₹11.94 | ₹8.57 | 39.32% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.624.156 crores during the period ended March 31, 2023 as compared to Rs.519.152 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.146.357 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.98.897 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.11.94 for the period ended March 31, 2023 as compared to Rs.8.07 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹624.156 crs | ₹519.152 crs | 20.23% |
| Net Profit | ₹146.357 crs | ₹98.897 crs | 47.99% |
| EPS | ₹11.94 | ₹8.07 | 47.96% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.2190.177 crores during the Financial Year ended March 31, 2023 as compared to Rs.2137.918 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.466.961 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.418.724 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.38.11 for the Financial Year ended March 31, 2023 as compared to Rs.35.63 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹2190.177 crs | ₹2137.918 crs | 2.44% |
| Net Profit | ₹466.961 crs | ₹418.724 crs | 11.52% |
| EPS | ₹38.11 | ₹35.63 | 6.96% |
Shares of Glenmark Life Sciences Ltd was last trading in BSE at Rs. 479.25 as compared to the previous close of Rs. 463.85. The total number of shares traded during the day was 41022 in over 2354 trades.
The stock hit an intraday high of Rs. 481.00 and intraday low of 464.05. The net turnover during the day was Rs. 19491097.00.
